Cann Group Ltd. ( (AU:CAN) ) has provided an announcement.
Cann Group Limited has signed supply agreements with eleven Chemist Warehouse pharmacy outlets in Queensland, marking a significant expansion of its market presence. These agreements, which have an initial two-year term, are expected to enhance Cann’s credibility and visibility in the marketplace, leveraging the Chemist Warehouse brand’s extensive reach and potentially leading to further expansion.
More about Cann Group Ltd.
Cann Group Limited is a company focused on enhancing patients’ lives through the development, production, and supply of innovative cannabis medicines. With research facilities and headquarters in Melbourne, Cann Group operates a large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. The company offers a range of dried flower and oil products, active pharmaceutical ingredients, and extracts to customers both in Australia and globally. Cann Group also owns Satipharm, known for its patent-protected capsule technology.
YTD Price Performance: 70.0%
Average Trading Volume: 1,400
Technical Sentiment Signal: Buy
Current Market Cap: $8.7M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.